Square Pharmaceuticals PLC. (DSE:SQURPHARMA)
210.30
-0.10 (-0.05%)
At close: May 6, 2026
-1.73% (1Y)
| Market Cap | 186.51B -4.5% |
| Revenue (ttm) | 83.53B +10.1% |
| Net Income | 25.86B +10.0% |
| EPS | 29.18 +10.0% |
| Shares Out | 886.45M |
| PE Ratio | 7.21 |
| Forward PE | 6.31 |
| Dividend | 12.00 (5.70%) |
| Ex-Dividend Date | Nov 17, 2025 |
| Volume | 266,301 |
| Average Volume | 228,990 |
| Open | n/a |
| Previous Close | 210.40 |
| Day's Range | 210.00 - 211.10 |
| 52-Week Range | 198.00 - 236.00 |
| Beta | 0.10 |
| RSI | 41.03 |
| Earnings Date | Apr 29, 2026 |